Fecal Calprotectin Shown To Be Potential Biomarker for Crohn’s Disease Recurrence After Intestinal Resection

Fecal Calprotectin Shown To Be Potential Biomarker for Crohn’s Disease Recurrence After Intestinal Resection
New research revealed that fecal calprotectin levels may be a biomarker for assessing Crohn’s disease after intestinal resection. The study entitled ”Measurement of Fecal Calprotectin Improves Monitoring and Detection of Recurrence of Crohn’s Disease After Surgery” was published in Gastroenterology by Emily K. Wright from the Department of Gastroenterology, St Vincent’s Hospital and University of

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

2 comments

Leave a Comment

Your email address will not be published. Required fields are marked *